A Bibliography of Recent Pharmaceutical Care Articles on Pain Management and End-of-Life Care Issues

BIBLIOGRAPHY

• Abel S R. Tramadol: An alternative analgesic to traditional opioids and NSAIDs. J Pharm Care Pain Symptom Control. 1995; 3(1)5–29
   Google Scholar
• Allen J E. Risk factors and prevention strategies for adverse drug reactions. J Pharm Care Pain Symptom Control. 1995; 3(1)31–35
   Google Scholar
• American Medical Association, Council on Ethical and Judicial Affairs. Medical futility in end-of-life care: Report of the Council on Ethical and Judicial Affairs. JAMA. 1999; 281: 937–941
   PubMedGoogle Scholar
• Angarola R T, Middlekauff G P. A view of current law on withholding and withdrawing treatment at the end of life. J Pharm Care Pain Symptom Control. 1995; 3(3/4)113–125
   Google Scholar
• Baron M F. Death and dying. Am J Pharm Education. 1998; 62: 220–222
   Web of Science ®Google Scholar
• Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. JAMA. 1998; 279(23)1877–1882
   PubMed Web of Science ®Google Scholar
• Block S D, Sullivan A M. Attitudes about end-of-life care: A national cross-sectional study. J Palliative Medicine. 1998; 1(4)347–355
   PubMedGoogle Scholar
• Bonomi A E, Ajax M, Shikiar R, Halpern M. Cancer pain management: Barriers, trends, and the role of the pharmacist. J Amer Pharm Assn. 1999; 39(4)558–566
   Google Scholar
• Bressler L R, Geraci M C, Feinberg W J. Pharmacists' attitudes and dispensing patterns for opioids in cancer pain management. J Pharm Care Pain Symptom Control. 1995; 3(2)5–18
   Google Scholar
• Broomhead A, Kerr R, Tester W, O'Mera P, Maccarrone C, Bowles R, Bus B, Hodsman P. Comparison of a once-a-day sustained release morphine formulation with standard oral morphine treatment for cancer pain. J Pain Symptom Manage. 1997; 14(2)63–73
   PubMed Web of Science ®Google Scholar
• Cassell E J. Diagnosing suffering: A perspective. Annals Internal Medicine. 1999; 131(7)531–534
   PubMedGoogle Scholar
• Chapman C R, Gavrin J. Suffering and the dying patient. J Pharm Care Pain Symptom Control. 1995; 3(3/4)67–90
   Google Scholar
• Cleeland C S, Gonin R, Baez L, Loehrer P, Pandya K J. Pain and treatment of pain in minority patients with cancer: The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Annals Internal Medicine. 1997; 127(9)813–816
   PubMed Web of Science ®Google Scholar
• Cleeland C S. Cancer pain: A ten year perspective. J Pharm Care Pain Symptom Control. 1997; 5(2)5–16
   Google Scholar
• Coluzzi P H. Sublingual morphine: Efficacy reviewed. J Pain Symptom Manage. 1998; 16(3)184–192
   PubMedGoogle Scholar
• Curtiss C P. Assessment of pain and pain relief: Key to successful pain control. J Pharm Care Pain Symptom Control. 1997; 5(3)33–45
   Google Scholar
• Dalal S, Melzack R. Potentiation of opioid analgesia by psychostimulant drugs: A review. J Pain Symptom Manage. 1998; 16(4)245–253
   PubMedGoogle Scholar
• Doucette W R, Mays-Holland T, Memmott H, Lipman A G. Cancer pain management: Pharmacist knowledge and practice. J Pharm Care Pain Symptom Control. 1997; 5(3)17–31
   Google Scholar
• Drayer R A, Henderson J, Reidenberg M. Barriers to better pain control in hospitalized patients. J Pain Symptom Manage. 1999; 17(6)434–440
   PubMed Web of Science ®Google Scholar
• Emanuel E J, Daniels E R, Fairclough D L, Clarridge B R. The practice of euthanasia and physician-assisted suicide in the United States: Adherence to proposed safeguards and effects on physicians. JAMA. 1998; 280(6)507–513
   PubMed Web of Science ®Google Scholar
• Ferrante F M. Principles of opioid pharmacotherapy: Practical implications of basic mechanisms. J Pain Symptom Manage. 1996; 11(5)265–273
   PubMedGoogle Scholar
• Ferrell B A. Pain evaluation and management in the nursing home. Annals Internal Medicine. 1995; 123(9)681–687
   PubMedGoogle Scholar
• Ferrell B R. Patient and family caregiver perspectives. Oncology. 1999; 13(5 Suppl 2)15–19
   PubMedGoogle Scholar
• Ferrell B R, Virani R. Institutional commitment to improved pain management: Sustaining the effort. J Pharm Care Pain Symptom Control. 1998; 6(2)43–55
   Google Scholar
• Fohr S A. The double effect of pain medication: Separating myth from reality. J Palliative Medicine. 1998; 1(4)315–328
   PubMedGoogle Scholar
• Furstenberg C T, Ahles T A, Whedon M B, Pierce K L, Dolan M, Roberts L, Silberfarb P M. Knowledge and attitudes of health-care providers toward cancer pain management: A comparison of physicians, nurses, and pharmacists in the state of New Hampshire. J Pain Symptom Manage. 1998; 15(6)335–349
   PubMedGoogle Scholar
• Gagnon B, Bruera E. Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain. J Pain Symptom Manage. 1999; 18(2)120–125
   PubMed Web of Science ®Google Scholar
• Gordon D B, Stevenson K K, Griffie J, Muchka S, Rapp C, Ford-Roberts K. Opioid equianalgesic calculations. J Palliative Medicine. 1999; 2(2)209–218
   PubMedGoogle Scholar
• Ground S, Radbruch L, Meuser T, Loick G, Sabatowski R, Lehmann K A. High-dose tramadol in comparison to low-dose morphine for cancer pain relief. J Pain Symptom Manage. 1999; 18(3)174–179
   PubMedGoogle Scholar
• Gureje O, Vo n Korff M, Simon G E, Gater R. Persistent pain and well-being: A World Health Organization study in primary care. JAMA. 1998; 280(2)147–151
   PubMed Web of Science ®Google Scholar
• Hanlon J T, Fillenbaum G G, Studenski S A, Ziqubu-Page T, Wall W E. Factors associated with suboptimal analgesic use in community-dwelling elderly. Annals Pharmacotherapy. 1996; 30: 739–744
   PubMedGoogle Scholar
• Hanson L C, Tulsky J A, Danis M. Can clinical interventions change care at the end of life?. Annals Internal Medicine. 1997; 126(5)381–388
   PubMed Web of Science ®Google Scholar
• Hospice Care. Hospice care and the pharmacist. Intl J Pharm Compounding. 1997; 1(1)11–13
   Google Scholar
• Jacox A, Carr D B, Mahrenholz D M, Ferrell B M. Cost considerations in patient-controlled analgesia. Pharmacoeconomics. 1997; 12: 109–120
   PubMedGoogle Scholar
• Jadad A R, Browman G P. The WHO analgesic ladder for cancer pain management: Stepping up the quality of its evaluation. JAMA. 1995; 274(23)1870–1873
   PubMed Web of Science ®Google Scholar
• Jamison R N. Comprehensive pretreatment and outcome assessment for chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage. 1996; 11(4)231–241
   PubMedGoogle Scholar
• Joranson D E, Ryan K M, Gilson A M, Dahl J L. Trends in medical use and abuse of opioid analgesics. JAMA. 2000; 283(13)1710–1714
   PubMed Web of Science ®Google Scholar
• Kilwein J H. Reflections on pain. J Clin Pharm & Therapeutics. 1998; 23: 327–329
   PubMedGoogle Scholar
• Krames E S. Rational use of opioids for nonmalignant pain. J Pharm Care Pain Symptom Control. 1997; 5(3)3–15
   Google Scholar
• Lenz K L, Marley E M. Pain management in the cancer patients. J Pharm Practice. 1998; 11(5)349–373
   Google Scholar
• Levy M H. Pain control in patients with cancer. Oncology. 1999; 13(5 Suppl 2)9–14
   PubMedGoogle Scholar
• Levy M H. Drug therapy: Pharmacologic treatment of cancer pain. N Engl J Med. 1996; 335(15)1124–1132
   PubMed Web of Science ®Google Scholar
• Lipman A G, Berry J I. Pharmaceutical care of terminally ill patients. J Pharm Care Pain Symptom Control. 1995; 3(2)31–56
   Google Scholar
• Lo B, Quill T, Tulsky J. Discussing palliative care with patients. Annals Internal Medicine. 1999; 130(9)744–749
   PubMed Web of Science ®Google Scholar
• Lothian S T, Fotis M A, VonGunten C F, Lyons J, Von Roenn J H, Weitzman S A. Cancer pain management through a pharmacist-based analgesic dosing service. Am J Health-Syst Pharm. 1999; 56: 1119–1125
   PubMedGoogle Scholar
• Mc Auley S W, Smith M C, Szeinbach S. Involvement of hospice pharmacists in withholding or withdrawing life-sustaining medications. J Pharm Care Pain & Symptom Control. 1996; 4(3)33–51
   Google Scholar
• McKenzie C A, Hobbs A E, Warrick L E. Pain management in the cancer patient. U. S. Pharmacist. 1997; 22, HS2, HS7–8, HS11–12, HS15–16
   Google Scholar
• Meier D E, Morrison R S, Cassel C K. Improving palliative care. Annals Internal Medicine. 1997; 127(3)225–230
   PubMed Web of Science ®Google Scholar
• Mercadante S, Fulfaro F. Alternatives to oral opioids for cancer pain. Oncology. 1999; 13(2)215–220
   PubMedGoogle Scholar
• Mercadante S, Casuccio A, Agnello A, Barresi L. Methadone response in advanced cancer patients with pain followed at home. J Pain Symptom Manage. 1999; 18(3)188–192
   PubMedGoogle Scholar
• Miller M G, McCarthy N, O'Boyle C A, Kearney M. Continuous subcutaneous infusion of morphine vs. hydromorphone: A controlled trial. J Pain Symptom Manage. 1999; 18(1)9–16
   PubMedGoogle Scholar
• Morley J S. New perspectives in our use of opioids. Pain Forum. 1999; 8(4)200–205
   Google Scholar
• Nelson J E. Saving lives and saving deaths. Annals Internal Medicine. 1999; 130(9)776–777
   PubMedGoogle Scholar
• Nelson K A, Glare P A, Walsh D, Groh E S. A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. J Pain Symptom Manage. 1997; 13(5)262–267
   PubMedGoogle Scholar
• O'Donnell J T, Richie M B, Nesbitt L A. Management of chronic nonmalignant pain. J Pharm Practice. 1998; 11(5)374–381
   Google Scholar
• Paice J A, Toy C, Shott S. Barriers to cancer pain relief: Fear of tolerance and addiction. J Pain Symptom Manage. 1998; 16(1)1–9
   PubMed Web of Science ®Google Scholar
• Paice J A, Penn R D, Shott S. Intraspinal morphine for chronic pain: A retrospective, multicenter study. J Pain Symptom Manage. 1996; 11(2)71–80
   PubMed Web of Science ®Google Scholar
• Pappagallo M. The concept of pseudotolerance to opioids. J Pharm Care Pain Symptom Control. 1998; 6(2)95–98
   Google Scholar
• Pargeon K L, Hailey B J. Barriers to effective cancer pain management: A review of the literature. J Pain Symptom Manage. 1999; 18(5)358–368
   PubMed Web of Science ®Google Scholar
• Patt R B, Ellison N M. Breakthrough pain in cancer patients: Characteristics, prevalence, and treatment. Oncology. 1998; 12(7)1035–1046
   PubMedGoogle Scholar
• Payne R. Issues pertinent to the revision of national guidelines. Oncology. 1998; 12(11A)169–175
   PubMedGoogle Scholar
• Pellegrino E D. Emerging ethical issues in palliative care. JAMA. 1998; 279(19)1521–1522
   PubMed Web of Science ®Google Scholar
• Phelps J R, Bormel F G. The politics of pain. J Pharm Care Pain Symptom Control. 1997; 5(2)27–35
   Google Scholar
• Portenoy R K. Current pharmacotherapy of chronic pain. J Pain Symptom Manage. 2000; 19(1 Suppl)S16–S20
   PubMed Web of Science ®Google Scholar
• Portenoy R K. Managing cancer pain poorly responsive to systemic opioid therapy. Oncology. 1999; 13(5 Suppl 2)25–29
   PubMedGoogle Scholar
• Portenoy R K, Dole V, Joseph H, Lowinson J, Rice C, Segal S, Richman B L. Pain management and chemical depenency: Evolving perspectives. JAMA. 1997; 278(7)592–593
   PubMedGoogle Scholar
• Portenoy R K. Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage. 1996; 11(4)203–217
   PubMed Web of Science ®Google Scholar
• Rich B A. Pain management: Legal risks and ethical responsibilities. J Pharm Care Pain Symptom Control. 1997; 5(1)5–20
   Google Scholar
• Riley K Y. Managing pain. The Consultant Pharmacist. 1998; 13(2)142–159
   Google Scholar
• Riley K Y. The role of the consultant pharmacist in hospice care. The Consultant Pharmacist. 1996; 11(12)1313–1315
   Google Scholar
• Ripamonti C, Bruera E. Current status of patient-controlled analgesia in cancer patients. Oncology. 1997; 11(3)373–384
   PubMedGoogle Scholar
• Rochon P A, Gurwitz J H. Prescribing for seniors: Neither too much nor too little. JAMA. 1999; 282(2)113–115
   PubMedGoogle Scholar
• Salzman R T, Roberts M S, Wild J, Fabian C, Reder R F, Goldenheim P D. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?. J Pain Symptom Manage. 1999; 18(4)271–279
   PubMed Web of Science ®Google Scholar
• Savage S R. Long-term opioid therapy: Assessment of consequences and risks. J Pain Symptom Manage. 1996; 11(5)274–286
   PubMed Web of Science ®Google Scholar
• Schuller A B, Hadden K, Perry F, Silverman J, Kielty M. Establishing a pain management program in a community hospital. J Pharm Care Pain Symptom Control. 1998; 6(3)5–20
   Google Scholar
• Simpson R K, Edmondson E A, Constant C F, Collier C. Transdermal fentanyl as treatment for chronic low back pain. J Pain Symptom Manage. 1997; 14(4)218–224
   PubMedGoogle Scholar
• Singer P A, Martin D K, Kelner M. Quality end-of-life care: patients' perspectives. JAMA. 1999; 281(2)163–168
   PubMed Web of Science ®Google Scholar
• Skaer T L. Cancer pain management. Am J Pharm Ed. 1998; 62: 182–189
   Google Scholar
• Sloan P A, Moulin D E, Hays H. A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage. 1998; 16(2)102–111
   PubMedGoogle Scholar
• Sulmasy D P, Lynn J. End-of-life care. JAMA. 1997; 277(23)1854–1855
   PubMed Web of Science ®Google Scholar
• Suri A, Estes K S, Geisslinger G, Derendorf H. Pharmacokinetic-pharmacodynamic relationships for analgesics. Intl J Clin Pharmacol Therap. 1997; 35(8)307–323
   PubMedGoogle Scholar
• Tangalos E G, Clackum S, Naeger L, Stuart B C. Assessment of chronic pain to achieve optimum outcomes. The Consultant Pharmacist—Geriatric Pharmacotherapy Special Issue. 1998; 13: 20–27
   Google Scholar
• Vaccarino A L. Tolerance to morphine analgesia. Pain Forum. 1999; 8(1)25–28
   Google Scholar
• Walsh D. Palliative management of the patient with advanced pancreatic cancer. Oncology. 1996; 10(9)40–44
   PubMedGoogle Scholar
• Wastila L J, Bishop C. The influence of multiple copy prescription programs on analgesic utilization. J Pharm Care Pain Symptom Control. 1996; 4(3)3–19
   Google Scholar
• Watling S M, Dasta J F, Seidl E C. Sedatives, analgesics, and paralytics in the ICU. Annals Pharmacotherapy. 1997; 31: 148–153
   PubMed Web of Science ®Google Scholar
• Whipple J K, Lewis K S, Quebbeman E J, et al. Analysis of pain management in critically ill patients. Pharmacotherapy. 1995; 15(5)592–599
   PubMedGoogle Scholar
• Winston C P, Johnson B W, Croghan M K, Moore M R, Khojastch A, Reder R F, Kaiko R F, Buckley B J. The use of controlled-release oxycodone for the treatment of chronic cancer pain: A randomized, double-blind study. J Pain Symptom Manage. 1998; 16(4)205–211
   PubMedGoogle Scholar
• Zhukovsky D S, Gorowski E, Hausdorff J, Napolitano B, Lesser M. Unmet analgesic needs in cancer patients. J Pain Symptom Manage. 1995; 10(2)113–119
   PubMedGoogle Scholar